Posted inComunicati
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE NAGOYA, Japan, April 6, 2026 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya,…









